Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Phenotypeca HPV vaccine
- Development stage
- Preclinical
- Lead developer
- Phenotypeca
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Administration
- Intramuscular
01
Overview
Phenotypeca's HPV vaccine is a multi-valent recombinant protein vaccine currently in early-stage development for the prevention of Human Papillomavirus (HPV) infection. The vaccine is produced using Phenotypeca's proprietary *Saccharomyces cerevisiae* yeast strain engineering platform, which employs Quantitative Trait Loci (QTL) mapping to optimize the expression and yield of recombinant viral antigens. This technology is designed to facilitate the low-cost, high-volume manufacturing of complex biologics, making the vaccine potentially more accessible for global health initiatives. The multi-valent formulation is intended to provide broad protection against multiple high-risk HPV genotypes associated with cervical cancer and other malignancies.
- Other names
- multi-valent HPV vaccine
Beyond the preview
Go deeper on Phenotypeca HPV vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Phenotypeca HPV vaccine.